Clinical trials
Diabetes Mellitus, Type 2 trials in Saudi Arabia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
| Recruiting | 4 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 16 |
| Eli Lilly and Company | 4 |
| King Saud University | 3 |
| Prince Sattam Bin Abdulaziz University | 3 |
| AstraZeneca | 2 |
| Boehringer Ingelheim | 2 |
| King Abdulaziz University | 2 |
| Princess Nourah Bint Abdulrahman University | 2 |
| Sanofi | 2 |
| Ashraf Abdelaal | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 50 |
| Diabetes Mellitus | 14 |
| Diabetes Mellitus, Type 1 | 3 |
| Obesity | 3 |
| Cardiovascular Diseases | 2 |
| Glucose Metabolism Disorders | 2 |
| Hypoglycemia | 2 |
| Insulin Resistance | 2 |
| Mobility Limitation | 2 |
| COVID-19 | 1 |
Trials
Showing 76 to 50 of 50. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.